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Abstract
Tuberculosis (TB) caused by Mycobacterium tuberculosis is one of the leading fatal infectious diseases. The development of
TB vaccines has been recognized as a major public health priority by the World Health Organization. In this study, three
candidate antigens, ESAT-6 (6kDa early secretory antigenic target) and Mtb72F (a fusion polyprotein from two TB antigens,
Mtb32 and Mtb39) fused with cholera toxin B-subunit (CTB) and LipY (a cell wall protein) were expressed in tobacco and/or
lettuce chloroplasts to facilitate bioencapsulation/oral delivery. Site-specific transgene integration into the chloroplast
genome was confirmed by Southern blot analysis. In transplastomic leaves, CTB fusion proteins existed in soluble
monomeric or multimeric forms of expected sizes and their expression levels varied depending upon the developmental
stage and time of leaf harvest, with the highest-level of accumulation in mature leaves harvested at 6PM. The CTB-ESAT6
and CTB-Mtb72F expression levels reached up to 7.5% and 1.2% of total soluble protein respectively in mature tobacco
leaves. Transplastomic CTB-ESAT6 lettuce plants accumulated up to 0.75% of total leaf protein. Western blot analysis of
lyophilized lettuce leaves stored at room temperature for up to six months showed that the CTB-ESAT6 fusion protein was
stable and preserved proper folding, disulfide bonds and assembly into pentamers for prolonged periods. Also, antigen
concentration per gram of leaf tissue was increased 22 fold after lyophilization. Hemolysis assay with purified CTB-ESAT6
protein showed partial hemolysis of red blood cells and confirmed functionality of the ESAT-6 antigen. GM1-binding assay
demonstrated that the CTB-ESAT6 fusion protein formed pentamers to bind with the GM1-ganglioside receptor. The
expression of functional Mycobacterium tuberculosis antigens in transplastomic plants should facilitate development of
a cost-effective and orally deliverable TB booster vaccine with potential for long-term storage at room temperature. To our
knowledge, this is the first report of expression of TB vaccine antigens in chloroplasts.
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Introduction
Tuberculosis (TB) caused by Mycobacterium tuberculosis (MTB), is
one of the leading bacterial infections that is re-emerging due to
drug resistant strains worldwide. The World Health Organization
(WHO) estimated the global burden of TB in 2010 to be 8.8
million cases and 650,000 cases of multi drug resistant TB (MDR-
TB) [1]. TB is also the leading cause of death in HIV-infected
patients as immunosuppression amplifies the risk of reactivation of
TB. Bacillus Calmette Guerin (BCG), an attenuated strain of
Mycobacterium bovis is the only available licensed vaccine against
TB. Many trials that evaluated BCG on the basis of protective
immunity and age of vaccination have been inconsistent and
variable, ranging from 0 to 80% efficacy [2–5]. In adults, BCG
blocks neither the development of latent TB nor revival of
pulmonary TB but prevents childhood TB [6]. In mice, BCG
vaccination provided protection up to 20 weeks postvaccination
but the effectiveness gradually declined and was ultimately lost at
40 weeks postvaccination [7]. To confer protection, currently
research groups are engaged in developing more efficient anti-TB
vaccines which may have the potential to replace BCG as
a primary TB vaccine or act as an effective boosting vaccine
following BCG vaccination to augment protection ability [5,6,8–
11]. Additional protection was not observed after BCG revaccina-
tion in randomized trials [12,13]. Therefore, BCG itself does not
execute the role of an effective booster vaccine in individuals
already vaccinated with BCG or having latent TB probably for the
reason that BCG induced immunity is conferred by its initial
replication [6]. Thus far, only couple of replacement vaccines with
higher or equal protective efficacy than BCG has emerged.
Therefore, a competent prime-boost regimen strategy is to give
BCG or replacement vaccine in childhood followed by an effective
subunit booster vaccine at a later age. In animal models, a number
of booster vaccine candidates administered at separate time gaps
ranging from 15 days to 6 weeks have shown better protection
than BCG alone [14]. Compared to attenuated live TB vaccines,
subunit vaccines offer several advantages including safety, efficacy
and are better suited for standardization [15,16]. On the other
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hand, limitations include poor immunogenicity of purified
antigens and restriction in the number of antigens exposed. This
makes an immunostimulatory component all the more essential in
an effective vaccine.
Many different elements of MTB have been proposed as
subunit vaccine candidates including surface components and
secreted proteins. Some of the promising antigens include ESAT-
6, Ag85B, MTB72F and LipY. Any mycobacterial antigen which
activates both CD4 & CD8 T- cells and imparts protective
immunity is an ideal candidate for subunit vaccination against TB.
Antigenic proteins actively secreted during the early phase of
growth of MTB are best suited for TB subunit vaccines [17].
ESAT-6 (6kDa early secretory antigenic target) is one such
promising vaccine antigen candidate that can strongly elicit
a specific T-cell response [18]. ESAT-6 has been established to be
present in the RD-1 region in all virulent strains of MTB but is
absent in the attenuated BCG vaccine strain [19]. Hence ESAT-6
could prove to be one of the components essential to treat this
complex disease. It is reported to induce production of gamma
interferon (IFN-c), a marker for protective immune response
[15,20] with protective immunity comparable to BCG [18]. The
vaccines based on ESAT-6 antigen in combination with another
mycobacterial antigen Ag85B have entered human clinical trials
[21]. Another attractive vaccine antigen candidate is Mtb72F,
a recombinant fusion polyprotein from two known TB antigens
Mtb32 and Mtb39. Mice immunization with the recombinant
protein Mtb72F, formulated in two different adjuvant systems -
AS01B and AS02A (GlaxoSmithKline Biologicals proprietary
adjuvants), resulted in the induction of strong immune response
[16]. It was also reported that vaccinated mice were protected
against aerosol challenge with a virulent strain of MTB [22]. In
addition, vaccination with Mtb72F formulated in AS02A or
AS01B protected mice against the central nervous system (CNS)
challenge with Mycobacterium tuberculosis H37Rv [16].
LipY, a TB cell wall protein and lipase, is up-regulated during
dormancy and active mycobacterium infection of macrophages.
Serum from tuberculosis patients has already been shown to cause
a humoral (IgG and IgM) response against LipY. Therefore, LipY
may serve as a B-cell antigen. As lipases are active in M
tuberculosis’s latent phase, drugs and vaccines can be targeted to
latent phase cells, a current limitation to M. tuberculosis
treatment, which requires an active infection [23,24].
Mycobacterial antigens as subunit vaccines have been targeted
by different delivery systems including recombinant viral vector
system [25], recombinant bacterial vector system [26] and
lipoglycan - protein conjugate system [27]. In this study, we
developed an oral delivery system for tuberculosis antigens to be
targeted to the gut associated lymphoid tissue (GALT) – an
integral part of the mucosal immune system. As M. tuberculosis is
a respiratory pathogen, subunit vaccination targeting the mucosa
is well suited to initiate both mucosal and systemic immune
response. In order to survive the extreme physiological conditions
of the gut, the antigens are protected via bio-encapsulation within
plant cells [28,29].
Cholera toxin B subunit is a well-known mucosal adjuvant that
has been reported as carrier molecule for mucosal immune
responses [30]. It has been reported that adjuvanticity of CTB
increases when coupled with foreign antigens. This could be
attributed to better uptake of antigen across the mucosal linings
and efficient antigen presentation to dendritic cells and macro-
phages. The type of the antigen fused to CTB plays an important
role in the outcome of immune response [31]. ESAT-6 and
Mtb72F are established immunodominant T-cell antigens. There-
fore, CTB fused with TB antigens could potentiate systemic and
mucosal immune response. Plant vaccines are highly efficient
delivery vehicles as they are capable of transporting antigen in an
encapsulated form. In animal trials, many plant oral vaccines with
foreign proteins fused to CTB expressed in chloroplasts have
shown to be protected against degradation by stomach enzymes
and offer protective immunity against disease states [29,32,33].
Recombinant ESAT-6 has been expressed in transient plant
production systems such as potato virus X vector based system
(PVX) in tobacco plants, tobacco mosaic virus vector based system
and Agrobacterium mediated transformation in Arabidopsis plants but
none of them are suitable for oral delivery [34–36]. Expression of
the TB antigens in plants through chloroplast transformation has
several advantages over other production systems. Transplastomic
plants lack transgene silencing in spite of accumulating .100-fold
higher transcripts than nuclear transgenic plants [37,38]. High
levels of expression (up to 72% of total leaf protein) of several
biopharmaceutical proteins and vaccine antigens have been
attained via the chloroplast system [39–41]. Hyper-expression of
the biopharmaceuticals in chloroplast facilitates cost-effective
production without expensive purification methods and cold
storage/transportation. Plant chloroplasts facilitate formation of
disulfide bonds [33] and other post-translational modifications
[42]. The functionality of chloroplast-derived vaccine antigens has
been validated by several assays including the macrophage lysis
assay [43], GM1-ganglioside binding assay [32,44] and immune
response to challenge by pathogens [29] or toxins [43]. In
comparison to mammalian expression systems, there is minimal
risk of animal or human pathogens contamination [43].
Additionally, chloroplast genomes facilitate transgene containment
preventing escape through pollen because of maternal inheritance
of the plastid genome [37,45]. Also, total elimination of any
reproductive structures is achieved when therapeutic proteins are
harvested from leaves.
In this study, ESAT-6 or Mtb72F fused with CTB and LipY was
expressed in tobacco as a model system for production, followed
by development of CTB–ESAT6 and LipY expression in lettuce
chloroplasts for oral delivery of TB vaccine antigens. The
lyophilization performed on lettuce leaves provided stability, long
term storage of antigens and increase in CTB–ESAT6 antigen
content by 22 fold with proper folding, disulfide bonds formation
and assembly into pentamers. GM1 ELISA assay confirmed
binding affinity of CTB–ESAT6 to GM1 receptors. Hemolysis
assay demonstrated dose dependent hemolytic activity of CTB–
ESAT6 in red blood cells.
Materials and Methods
Construction of Chloroplast Transformation Vectors
The ESAT-6 and LipY sequence was amplified using sequence-
specific restriction-site flanking primers and Mycobacterium tubercu-
losis genomic DNA as template. The PCR product was then
cloned into the pCR BluntII Topo vector (Invitrogen) and
sequenced to check any errors. Following SmaI/XbaI digestion,
the ESAT-6 gene was ligated into the pLD Ctv 5CP chloroplast
transformation vector [33] to create pLD-CTB-ESAT6. The LipY
sequence was released by NdeI/XbaI digestion and ligated to pLD-
Utr vector to construct pLD-LipY. The CTB sequence was
amplified using sequence specific primers and pLD Ctv 5CP [33]
vector as the template. Mtb72F [22] was generated by amplifying
each individual fragment (Mtb32c192–323, SmaI at 59 end and
BamHI at 39 end; Mtb39, BamHI at 59 end and EcoRI at 39 end;
and Mtb32n1–195, EcoRI at 59 end and HindIII at 39 end) from
Mycobacterium tuberculosis genomic DNA using sequence specific
primers and sequentially linking in tandem the 14-kDa C-terminal
Oral Delivery of Tuberculosis Vaccine Antigens
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fragment of mtb32 to the full-length fragment of mtb39, followed
by the 20-kDa N-terminal portion of mtb32. Further, the
sequences were confirmed to verify any errors and assembled as
CTB-Mtb72F into the pBSSK+ (Stratagene, La Jolla, CA, USA)
vector. The CTB-Mtb72F was then sub cloned into the tobacco
chloroplast transformation vector to obtain pLD-CTB-Mtb72F.
Lettuce flanking sequence vector (pLSLF) was used to integrate
the transgene into transcriptionally active spacer region between
trnI and trnA genes as explained previously [33,46]. The CTB-
ESAT6 sequence was assembled and subcloned in pDVI-1 vector
[40]. LipY sequence was also subcloned in pDVI-1 vector. The
CTB-ESAT6 and LipY expression cassettes regulated by psbA
promoter, 59 and 39 Utr was then ligated into the pLsDV vector to
make lettuce chloroplast transformation vectors pLsDV-CTB-
ESAT6 and pLsDV-LipY. To facilitate proper folding of protein,
both fusions (CTB-ESAT6 and CTB-Mtb72F) had the GPGP
hinge in between fusion proteins for reducing the steric hindrance.
In this study, LipY was not fused to CTB. Oral delivery of plant
cells expressing subunit vaccine candidates, without fusion to CTB
has been shown to elicit immunogenic response and/or confer
protection against pathogen challenge [29,47–49]. Therefore,
LipY was first expressed without CTB fusion but future studies will
consider using CTB fusion.
Bombardment and Selection of Transgenic Plants
Chloroplast transformation including bombardment and re-
generation was carried out as described previously [40,46]. In
brief, sterile fully expanded leaves placed on MS medium with
abaxial side up for tobacco (Nicotiana tabacum var Petite Havana
and LAMD-609) and adaxial side up for lettuce (Lactuca sativa cv
Simpson Elite) were bombarded with gold particles coated with
plasmid DNA of pLD-CTB-ESAT6, pLD-CTB-Mtb72F, pLD-
LipY, pLsDV-LipY and pLsDV-CTB-ESAT6 respectively using
the biolistic device PDS1000/He (Bio-Rad). After incubation at
25uC in the dark for 2 days, the leaves were cut into small (,5
mm2) pieces and placed on the regeneration medium of plants
(RMOP) containing spectinomycin dihydrochloride 500 mg/l (for
Petite Havana), 200 mg/l (for LAMD) and modified LR re-
generation medium of lettuce prepared with spectinomycin
dihydrochloride 50 mg/l (for lettuce) with bombarded side facing
the medium [40]. The transgenic shoots appeared after about 4–8
weeks and were screened for transgene integration by PCR as
described previously [46]. PCR positive shoots underwent an
additional selection on their corresponding regeneration medium
to achieve homoplasmy and were rooted in half-strength MS
medium containing spectinomycin of concentrations mentioned
earlier. Rooted plants were transferred to Jiffy peat pots and
placed in incubator for acclimatization. After considerable growth,
plants were moved to green house for maturation and seed
production. In order to confirm maternal inheritance, seeds
harvested from self-pollinated CTB-ESAT6 transplastomic lettuce
plants were germinated on K MS salt supplemented with
spectinomycin (100 mg/l for lettuce). Sterilization of seeds was
performed with 25% bleach, followed by thorough rinsing in
distilled water. Seeds from untransformed plants were also
inoculated in the same plate. More than ten plates were screened
with 15–20 seeds per plate. The plates were observed after 10
days.
Confirmation of Transgene Integration into the
Chloroplast Genome by Southern Blot Analysis
To confirm the transgene cassette(s) integration into the
chloroplast genome, genomic DNA was extracted from leaf tissues
of spectinomycin resistant and wild-type untransformed plants
using Qiagen DNeasy Plant Mini Kit (Qiagen, Valencia, CA).
Southern blot analysis was carried out to confirm site specific
integration and to determine homoplasmy as described previously
[46,50]. Regenerated chloroplast transgenic lines were analyzed to
determine whether homoplasmy was attained with all the copies of
the chloroplast genome containing stably integrated transgene. In
brief, 2–5 mg of genomic DNA of both tobacco (CTB-ESAT6 and
CTB-Mtb72F) and lettuce (CTB-ESAT6) were digested complete-
ly with HindIII enzyme and run on a 0.7% (w/v) Tris-Acetate
EDTA (TAE) agarose gel and transferred to a nylon membrane
(N+-Bond, Amersham Biosciences, USA) by capillary action.
Similarly, LipY tobacco genomic DNA was digested with SmaI and
transferred to nylon membrane. The P32 labeled flanking sequence
probe was generated and used for Southern blot analysis of
transplastomic plants. Pre-hybridization and hybridization were
carried out using hybridization solution (Stratagene QUICK-
HYB, La Jolla, CA) according to manufacturer’s protocol. The
membrane was exposed to X-ray film in a cassette at 280uC for 2
days.
Detection of Fusion Protein Using Western Blot Analysis
Transformed and untransformed leaves (,100 mg) were
ground in liquid nitrogen with a mortar and pestle followed by
extraction with a mechanical pestle in 200 ml of plant extraction
buffer (200 mM Tris-HCl, pH 8.0, 100 mM NaCl, 100 mM
DTT, 0.1%SDS, 400 mM sucrose, 0.05% Tween 20, 2 mM
PMSF and proteinase inhibitor cocktail (Roche). Some portion of
the homogenized material was aliquoted for soluble and insoluble
portions of the protein extract. The leaf extracts were then
centrifuged for 5 min at 10,000 rpm to separate out the
supernatant containing soluble fraction and pellet the insoluble
plant material. The pellet containing insoluble proteins was
resuspended in buffer and sonicated in ice for 10 s pulse for one
min. Bradford assay was performed to detect total protein
concentration using Protein Assay Dye Reagent Concentrate
(Bio-Rad). Standard curve for this assay was generated with
Bovine Serum Albumin (BSA) with dilutions ranging from
0.025 mg/ml to 0.8 mg/ml. All samples were loaded in duplicate
and absorbance was measured at 595 nm. Homogenate, super-
natant and pellet fractions were boiled for 5 min in sample buffer
(0.5M Tris-HCl, 25% glycerol, 10% SDS, 0.5% Bromophenol
blue and b-mercapto ethanol) and separated by sodium dodecyl
sulfate - polyacrylamide gel electrophoresis (SDS-PAGE) (Bio-
Rad). The separated proteins were then transferred on to
a nitrocellulose membrane in a transfer cassette (Bio-Rad) at
85V for 1 hour. After blocking with phosphate-buffered saline
(PBS), 0.1% Tween 20, 3% milk powder (PTM), the membrane
was incubated with anti-CTB primary antibody (1:4000, Sigma,
St. Louis, MO, USA) diluted in PTM followed by incubation with
1:5000 horseradish peroxidase (HRP) - conjugated goat anti-rabbit
secondary antibody (Southern biotech, Birmingham, AL, USA) for
1 hour 30 minutes. LipY protein was detected with rat anti-LipY
(DPE) serum. A Super Signal West Pico HRP Substrate Kit
(Pierce, Rockford, IL, USA) was used for autoradiographic
detection.
Enzyme Linked ImmunoSorbent Assay (ELISA)
To quantify the expression of the fusion protein, the enzyme
linked immunosorbent assay (ELISA) was performed. Approxi-
mately 100 milligram (mg) of the leaf samples at different
developmental stages (young, mature and old) or at different time
points (10 AM, 12 PM and 6 PM) were collected from plants
grown in the greenhouse exposed to sunlight. The extraction
buffer described above was used to isolate total leaf protein for this
Oral Delivery of Tuberculosis Vaccine Antigens
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assay. The CTB (sigma) protein standards and tested samples were
diluted in the coating buffer (15 mM Na2CO3, 35 mM NaHCO3,
3 mM NaN3, pH 9.6) with the concentration from 50 to 1000 ng/
mL and coated on to a 96 well ELISA plate overnight at 4uC.
Blocking was performed with PTM for 1 hour. The anti-CTB
primary antibody was used at 1:4000 dilution for 1 hour. Washes
were performed with 1x PBS, 0.1% tween (PBST) thrice followed
by washes with distilled water. HRP conjugated goat anti-rabbit
secondary antibody was used at 1:5000 dilution for 1 hour.
Washes were performed as mentioned above. Wells were then
loaded with 100 ml of 3, 3, 5, 5-tetramethylbenzidine (TMB;
American Qualex) substrate and incubated for 10 to 15 min at
room temperature. The reaction was terminated by adding 50 ml
of 2N H2SO4 per well, and the plate was read on a plate reader
(Dynex Technologies) at 450 nm.
Densitometry Analysis
To quantify the expression of fusion protein in transplastomic
CTB-ESAT6 lettuce plants, densitometric analysis was performed
on the immunoblots with CTB antibody. Known concentrations
of purified CTB (Sigma) were used as standards (25, 50, 75 and
100 ng) to create a standard curve. Total protein concentration
was measured using Bradford assay (Bio-Rad). Fusion protein was
loaded in different concentrations of total protein and their
Integrated Density value (IDV) was measured using Alpha imager
2000 and analyzed using Alphaease software. The percentage of
fusion protein (% Total leaf protein) and amount of transgenic
protein (mg/g) is calculated based on the formula published earlier
[46].
Lyophilization
Lettuce leaves expressing CTB–ESAT6 were frozen in liquid
nitrogen and then lyophilized in Freezone Benchtop Freeze Dry
Systems (Labconco) in vacuum (0.036 mBar) for 2 days at 250uC.
Lyophilized leaves were stored at room temperature in vacuum for
few days and ground to fine powder in waring blender. Ground
lyophilized leaf tissue was normalized with fresh leaf tissue based
on its dry weight. Immunoblots were performed with 5 mg of
lyophilized tissue and 100 mg of fresh tissue since we observed
95% decrease in weight due to removal of water content. The
GM1 ELISA binding assay was performed as described below to
confirm stability of fusion protein in lyophilized tissue.
GM1 - Ganglioside Receptor Binding Assay
GM -1 ganglioside (Sigma G-7641) and BSA (control) was
coated at a concentration of 3 mg/ml in bicarbonate buffer
(15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) on to a 96 well plate
at 4uC overnight. Washing was performed thrice with 1X PBST
and water. The wells were then blocked with 200 ml of PTM for 2
hours at 37uC followed by washing thrice with 1x PBST and
water. Untransformed plant leaf TSP, transformed leaf TSP
(extracted in bicarbonate buffer) and CTB protein standards
diluted in ELISA coating buffer were coated on to the plate in
different concentrations and incubated for 2 hours at 37uC. The
plate was washed again as stated above and incubated with anti -
CTB primary antibody (1:3000 dilution) for 1 hr at 37uC. Further,
the plate was incubated with secondary HRP-conjugated goat
anti-rabbit IgG in 1:4000 dilution. Following washing with 1X
PBST and water thrice, 100 ml of TMB substrate was added and
incubated for 10 to 15 min at room temperature. The reaction
was terminated by adding 50 ml of 2 N H2SO4 per well and the
absorbance was read on a plate reader at 450 nm.
Affinity Purification
Total leaf protein from CTB–ESAT6 lettuce transplastomic
plants was extracted with 2X PBS (pH 8) containing 0.1% Tween
20 and proteinase inhibitors by sonication (Sonicator 3000
Misonix) for 1 min in ice. Supernatant was obtained after
centrifuging for 5 min at 2000 rpm. Pre-clearing of the superna-
tant was performed with 100 mg of Protein A Sepharose CL-4B
(GE Healthcare) beads along with protease inhibitors (Roche)
overnight at 4uC. Rabbit anti-cholera toxin B subunit polyclonal
antibody (Abcam, ab34992) was coated on to washed protein A
beads in a ratio of 50 mg/200 ml in 1X PBS overnight at 4uC for
antibody binding to beads. Washes were performed with 1X PBS
followed by 0.1M sodium borate buffer (pH 9). Dimethyl
pimelimidate - DMP (20mM, Sigma D8388) cross linker in
sodium borate buffer was added to the bead- antibody mixture
and incubated for 30 min at room temperature twice. Washes
were continued with 50 mM glycine (pH 2.5) followed by 1X PBS.
Cross linked antibody was added to the precleared supernatant
and incubated overnight at 4uC. Elutions were performed with
100 ml glycine buffer (100 mM, pH 2.5) containing 10 ml of 1M
Tris-HCl (pH 9) for neutralization at room temperature. All
elution fractions were analyzed by Bradford assay (Bio-Rad) and
nanodrop spectrophotometer via absorbance at 280 nm for total
protein concentration in mg/ml. Silver staining was performed to
detect % purity.
Silver Staining
SDS-PAGE gel (12%) was fixed using a fixative (50% methanol,
12% acetic acid) overnight at 4uC and washed twice with 50%
ethanol. The gel was pretreated with 0.02% sodium thiosulphate
solution (Na2S2O3) for 1 min and then washed thrice in distilled
water for 1 min each. Gel was stained with Silver nitrate solution
(0.2% silver nitrate in formalin) for 20 min. The gel was rinsed
twice in distilled water for 1 min and developer solution (2%
Na2CO3, 0.0004% Na2S2O3, formalin) was added. Gel was
shaken to observe bands in developer solution. Developer solution
was replaced after 5 min and reaction was stopped with 1% acetic
acid as soon as protein bands were observed.
Hemolysis Assay
To test the hemolytic activity of the ESAT-6 protein, hemolysis
assay was performed with affinity purified CTB–ESAT6 fusion
protein. Pore formation in red blood cell membranes can be
measured by hemolysis assay as shown previously [51]. Affinity
purified CTB – ESAT-6 was solubilized with 0.1M KCl – HCl for
1 min followed by neutralizing with 50 mM Tris - HCl (pH 8) as
described earlier [52,53]. After solubilization, CTB-ESAT6 fusion
protein was mixed in 1:2 ratio with sheep red blood cells (16109
cells) in a microcentrifuge tube and incubated at 32uC for 2 hours.
Non solubilized CTB-ESAT6, distilled water and PBS incubated
with sheep red blood cells in the same ratio and under same
conditions were used as controls. The cells were then resuspended
and centrifuged for about 7 min at 4000 rpm. Supernatants were
loaded on to 96 well plate and absorbance of the supernatants was
read at 405 nm.
Results
Tobacco and Lettuce Chloroplast Vectors Containing TB
Antigens
Tobacco chloroplast vectors pLD-CTB-ESAT6, pLD-CTB-
Mtb72F and pLD-LipY were constructed with CTB-ESAT6,
CTB-Mtb72F and LipY coding sequences as subunit vaccine
candidates (Figure 1). The lettuce chloroplast vectors pLsDV-
Oral Delivery of Tuberculosis Vaccine Antigens
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CTB-ESAT6 and pLsDV-LipY harboring CTB-ESAT6 and LipY
respectively were also created (Figure 1). Both CTB-ESAT6 and
CTB-Mtb72F contained GPGP (Gly Pro Gly Pro) hinge at the
junction of fusion proteins to assist in correct folding of each
protein by reducing the steric hindrance. The tobacco vectors
contained homologous flanking sequences 16S/trnI and trnA
whereas lettuce vectors had longer flanking sequences containing
16S/trnI and trnA/23S (Figure 1) to facilitate recombination with
the native chloroplast genome. The expression of CTB-ESAT6,
CTB-Mtb72F and LipY was regulated by the endogenous psbA
promoter and 59 untranslated region (Utr) to achieve higher levels
of expression due to the presence of multiple ribosome binding
sites [40]. The psbA 39 Utr (TpsbA) located at the 39 end of the
introduced gene cassette, conferred transcript stability [54]. The
endogenous constitutive 16S rRNA operon promoter (Prrn) was
employed to regulate expression of the aadA (aminoglycoside 39
adenylyltransferase) gene with a GGAG ribosome binding site
upstream of the start codon AUG to confer spectinomycin
resistance. The 39 Utr of rbcL gene (TrbcL) downstream of aadA
gene provided transcript stability to aadA in lettuce vectors. The
final chloroplast transformation vectors pLD-CTB-ESAT6, pLD-
CTB-Mtb72F, pLD-LipY, pLsDV-CTB-ESAT6 and pLsDV-
LipY were sequenced and used for transformation studies.
Analysis of Transplastomic Plants for Site-specific
Transgene Integration
A total of 9 (per 30 bombardments) and 26 (per 40
bombardments) independent spectinomycin resistant tobacco
shoots were obtained with pLD-CTB-Mtb72F and pLD-CTB-
ESAT6 vectors, respectively. Four independent spectinomycin
resistant lettuce shoots were recovered from leaves bombarded
with pLsDV-CTB-ESAT6 vector coated on gold particles.
Comparable numbers of transplastomic tobacco and lettuce shoots
were also obtained with LipY harboring vectors. Site-specific
transgene integration of independent spectinomycin resistant
shoots was verified by polymerase chain reaction (PCR) using
3P/3M and 5P/2M primer pairs in tobacco and 16SF/3M and
5P/2M primer pairs in lettuce (data not shown) as described
previously [46]. Untransformed plants did not show any PCR
product. Nuclear transformants could be distinguished because 3P
or 16SF will not anneal and mutants were identified because 3M
will not anneal and thus shoots that have nuclear integration or
spontaneous mutation of the 16S rRNA gene were eliminated.
Following PCR analysis, transplastomic plants were subjected to
two additional rounds of selection (second and third) to promote
homoplasmy. Southern blot analysis was performed to determine
homoplasmy or heteroplasmy and to supplement the PCR
confirmation of site-specific transgene integration. The flanking
sequence probe allowed detection of site-specific integration of the
gene cassette into the chloroplast genome as it hybridizes with the
trnI and trnA genes. The transformed chloroplast genome digested
with HindIII produced fragments of 9.5 kb for pLD-CTB-ESAT6
(Figure 2A), 10.9 kb for pLD-CTB-Mtb72F (Figure 2B) and
11.49 kb for pLsDV-CTB-ESAT6 (Figure 2C), when hybridized
with flanking sequence probe. The untransformed tobacco and
lettuce chloroplast genome digested with HindIII produced
Figure 1. Schematic representation of chloroplast transformation vectors harboring tuberculosis candidate vaccine antigens. Ls,
Lactuca sativa; Nt, Nicotiana tabacum; pLD- vector components: the homologous Nicotiana tabacum chloroplast genome flanking sequence
comprising of 16S 39 end sequences and complete trnI, trnA genes; pLs- vector components: 16S trnI, the homologous Lactuca sativa chloroplast
genome long flanking sequence containing 16S 39end sequences and full length trnI gene; trnA 23S, trnA gene and 59end of the 23S ribosomal RNA
subunit; Prrn, ribosomal RNA operon promoter with GGAGG ribosome binding site; aadA, aminoglycoside 39-adenylytransferase gene; TrbcL, 39
untranslated region (Utr) of rbcL gene; PpsbA, promoter and 59 Utr of psbA gene; TpsbA, 39 Utr of psbA gene; CTB-ESAT6, coding sequence of cholera
toxin B subunit fused to ESAT6 (6 kDa early secretory antigenic target); CTB-Mtb72F, coding sequence of cholera toxin B subunit fused to
a recombinant fusion polyprotein from two TB antigens Mtb32 and Mtb39; LipY, coding sequence of a TB cell wall protein with lipase activity.
doi:10.1371/journal.pone.0054708.g001
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a 7.67 kb fragment and 9.11 kb fragment respectively confirming
that these plants lacked foreign genes (Figure 2A–2C). The
untransformed tobacco digested with SmaI generated a 4.0 kb
fragment whereas a ,7.0 kb fragment was detected in LipY
transformed chloroplast genomes (Figure 2D). The hybridization
with flanking sequence probe revealed if homoplasmy of the
chloroplast genome was achieved through several rounds of
selection. Absence of 4.0 kb, 7.67 kb and 9.11 kb fragment in
LipY tobacco, CTB-ESAT6 tobacco and lettuce transplastomic
lines respectively confirmed homoplasmy (within the detection
limits of Southern blot) and site-specific integration of foreign
genes into the chloroplast genome (Figure 2A, 2C and 2D).
However, for CTB-Mtb72F transplastomic plants, homoplasmy
could not be achieved even after several rounds of selection on
stringent selection medium containing spectinomycin, as both
10.9 kb and 7.67 kb fragments corresponding to transformed and
untransformed genomes were detected in Southern blots
(Figure 2B). Plants confirmed by Southern analysis were trans-
ferred to jiffy pellets and placed in 16 hr light/8 hr dark cycle
incubator for acclimatization. Later, the plants were transferred to
the greenhouse for maturation and seeds were collected. Tobacco
transplastomic plants showed no visible difference when compared
with the wild type plants and maintained normal growth and
morphology in our experimental conditions (data not shown). On
the other hand, lettuce T0 CTB-ESAT6 transplastomic plants
showed detrimental signs of development with delayed growth.
However, T1 plants were healthy and showed normal growth
patterns (data not shown).
Seeds collected from CTB-ESAT6 T0 transplastomic and
untransformed lettuce plants were germinated onK MS medium
with spectinomycin in the same plate. All T1 CTB-ESAT6 lettuce
seeds germinated and developed into uniformly green plants (data
not shown). This lack of Mendelian segregation of genes confirmed
maternal inheritance of transgenes. None of the untransformed
seeds germinated on the selection media whereas all untrans-
formed seeds germinated when placed on media without the
selection agent. After prolonged periods of germination, few seeds
germinated and bleaching of germinated seedlings was observed in
untransformed seeds. Further, after transfer to the greenhouse, all
T1 plants flowered, set seeds and showed similar phenotype when
compared to untransformed plants.
Western Blot Analysis for Detection of Foreign Protein in
Transplastomic Plants
In order to evaluate protein solubility, expression of the fusion
proteins ESAT-6 and Mtb72F was analyzed by immunoblots with
distinct extraction fractions (homogenate, supernatant and pellet)
of leaf extracts using anti-CTB polyclonal antibody. Under
reducing conditions, blots probed with anti-CTB polyclonal
antibody revealed full-length fusion protein with apparent
molecular mass of 23 kDa for tobacco CTB-ESAT6 (CTB-
ESAT6-Nt, Figure 3A). Additional 69 kDa protein was also
detected indicating the trimeric form of the fusion protein in
Figure 2. Southern blot analysis to evaluate site-specific transgene integration and homoplasmy in transplastomic plants. An
autoradiograph of Southern blot hybridized with flanking sequence probe comprising of trnI and trnA gene sequences. A, Homoplasmy in CTB-ESAT6
tobacco (Nt) transplastomic lines. B, Heteroplasmy in CTB-Mtb72F tobacco (Nt) transplastomic lines. C, Homoplasmy in CTB-ESAT6 lettuce (Ls)
transplastomic lines. D, Homoplasmy in LipY tobacco (Nt) transplastomic lines. Lane N, untransformed plant; Lane 1 to 6, transplastomic lines; Lane M,
1 Kb+ DNA ladder.
doi:10.1371/journal.pone.0054708.g002
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tobacco chloroplasts (Figure 3A). In lettuce CTB-ESAT6 (CTB-
ESAT6-Ls), the monomeric form of fusion protein corresponding
to 23 kDa was observed under reducing conditions (Figure 3B).
The trimeric 69 kDa form of CTB-ESAT6 was not detected in
lettuce probably due to differences in the conditions between
lettuce and tobacco leaf extracts. During the extraction of proteins
from leaves, denaturing and reducing agents disrupt the trimeric
and other oligomeric forms of CTB-ESAT6 fusion protein into the
monomeric form. Under these conditions, fusion proteins are
exposed to proteases and could result in cleavage. Exclusion of
reducing and denaturing agents from plant extraction buffer
showed only the pentameric structure of the CTB-ESAT6 fusion
protein, without any cleaved products (Figure 3C). Under
reducing conditions, other oligomeric forms of CTB-ESAT6
fusion protein were not detected due to their disruption into
monomers. Under fully denatured and reduced conditions, only
monomeric protein band is expected instead of disulfide bonded
dimers or other oligomeric forms. Depending on the nature of
CTB fusion protein, only monomeric fusion protein or dimers,
trimers, tetramers and pentamers of the CTB fusion protein have
been observed previously [55–57].
Analysis of different extraction fractions of fusion protein CTB-
ESAT6 from both tobacco and lettuce indicated that most of the
fusion protein existed in the soluble form. Some of the fusion
protein was also detected in pellet under our experimental
conditions (Figure 3D & 3E). In contrast to CTB-ESAT6, CTB-
Mtb72F existed only in the soluble form and no fusion protein was
detected in pellet under our experimental conditions (Figure 3F).
Both tobacco and lettuce CTB-ESAT6 plants showed an
additional low molecular weight band of about 15 kDa with
anti-CTB antibody (Figure 3A & 3B). This fragment might have
been formed by proteolytic cleavage of fusion protein. Since, the
band is larger than CTB protein (11.6 kDa); cleavage should be
within ESAT6. In CTB-Mtb72F (CTB-Mtb72F-Nt) tobacco
plants, immunoblots with CTB antibody revealed the expected
83 kDa fusion protein besides a ,72 kDa protein band which is
due to cleavage at the C-terminal end of full length protein in the
Mtb72F region (Figure 3F). Several CTB-fusion proteins have
been expressed in chloroplasts and none of them showed cleavage
within the CTB protein [32,55–58]. The Peptide Cutter analysis
tool from the ExPASy server [59] was used to predict protein
cleavage sites in ESAT-6 and Mtb72F sequence. Peptide Cutter
identified several cleavage sites closer to N-terminus of ESAT-6
(,25 amino acid) indicating a higher probability of cleavage in
ESAT-6 protein. Various protease cleavage sites were also
detected in C-terminus of the Mtb72F sequence. However,
cleavage of fusion protein occurs only during the extraction of
proteins from leaves for western blot analysis under denaturing
and reducing conditions. Under these conditions, fusion protein is
exposed to proteases. As shown in CTB-ESAT6 (Ls) immunoblot,
fusion protein remained in the pentameric form and didn’t show
any cleavage when denaturing and reducing agents were excluded
from plant extraction buffer (Figure 3C).
The immunoblot analysis of LipY transplastomic tobacco
(LipY-Nt) and lettuce (LipY-Ls) plants with rat anti-LipY (DPE)
antibody showed non-specific binding at ,70 kDa in all samples
including the transformants and untransformed plants (Figure 3G
and 3H). Only transformed plants showed a ,40 kDa expected
size band along with ,25 kDa band which might have formed
due to the proteolytic cleavage of LipY protein in both lettuce and
tobacco. Similar to CTB-ESAT6, the LipY protein existed in both
soluble and insoluble fractions (Figure 3H).
Quantification of CTB-ESAT6 and CTB-Mtb72F in Tobacco
Plants Using ELISA
Expression levels of the fusion protein CTB-ESAT6 in
transplastomic tobacco plants at different developmental stages
and time of leaf harvest were quantified by ELISA using leaf
protein extracts prepared from young, mature and old leaves
harvested at 10 AM, 2 PM and 6 PM. Under normal illumination
conditions (16 h of light and 8 h of dark), the highest expression
level of up to 7.5% of total soluble protein (TSP) was observed in
mature leaves harvested at 6 PM, whereas in young and old leaves
the expression levels reached up to 3.4% and 5% of TSP at same
harvesting time (Figure 4A). The large accumulation of CTB-
ESAT6 (Nt) in mature tobacco leaves probably resulted from
higher number of well-developed chloroplasts and the high copy
number of chloroplast genomes. Likewise, decrease in CTB-
ESAT6 expression in young and old leaves could be due to less
number of developed chloroplasts and degradation of proteins
during senescence. Accumulation of CTB-ESAT6 (Nt) increased
over time during the day and reached the highest at 6 PM.
(Figure 4A). This could be attributed to 59 Utr and the psbA
promoter that enhances translation in light.
Although homoplasmic CTB-Mtb72F transgenic plants could
not be obtained in our experimental conditions, we still quantified
the expression of CTB-Mtb72F fusion protein in tobacco. The
accumulation of the fusion protein reached up to 1.1% of TSP in
mature leaves under the normal illumination even in highly
heteroplasmic lines (Figure 4B). The observed expression levels are
still much higher than other plant systems expressing TB vaccine
antigens reported in published literature [34].
Quantification of CTB-ESAT6 Fusion Protein in
Transplastomic Lettuce Plants by Densitometry
Immunoblots of different extraction fractions of CTB–ESAT6
lettuce transplastomic plants indicated the presence of fusion
protein in both supernatant and pellet (Figure 3E). Therefore,
CTB-ESAT6-Ls expression levels were determined on western
blots by comparing the homogenate fraction with known
quantities of purified CTB protein and analyzing them by spot
densitometry. Linearity of the standard curve was established
using 25, 50 and 75 ng of purified CTB, enabling the estimation of
CTB-ESAT6 expression. In lettuce, CTB-ESAT6 accumulated up
to 0.75% of total leaf protein (Figure 4C). Mature leaves showed
highest expression followed by young leaves (Figure 4C). Old
leaves showed lowest level of expression probably due to
senescence and proteolytic activity. Similarly different time points
of harvest were analyzed using densitometry. An increasing trend
from morning to evening with highest expression levels of fusion
protein at 6 PM was observed (Figure 4D).
Lyophilization of CTB-ESAT6 expressing lettuce leaves was
performed to facilitate storage at room temperature. In addition,
an increase in the amount of antigen per gram of leaf material
was observed. After lyophilization, leaves were reduced to 5–8%
of their fresh weight thereby increasing the CTB-ESAT6
antigenic content per gram of leaf material. Lyophilized
material was powdered and packaged into capsules (size zero,
Torpaq Inc.) to be delivered as oral vaccine (Figure 5A).
Analysis of lyophilized material on immunoblots with anti-CTB
antibody revealed same polypeptides as obtained with fresh leaf
material (Figure 5B). The undiluted and 10-fold diluted
lyophilized leaf samples didn’t show any difference in 23 kDa
band or cleaved 15 kDa polypeptide intensities in accordance
with the dilution factor, indicating saturation of signal in the
undiluted sample. The 20 fold diluted lyophilized sample
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Figure 3. Western blot analysis to detect expression of recombinant proteins in transplastomic plants. Immunoblots with anti CTB
antibody showing presence of expected size fusion protein band in CTB-ESAT6 tobacco (A) and CTB-ESAT6 lettuce (B) transplastomic lines.
Immunoblots showing pentameric CTB-ESAT6 fusion protein detection with protein extracted under non-reducing/non-denaturing conditions and
loaded on SDS-PAGE without boiling (C). Immunoblots showing distribution of recombinant fusion protein in the homogenate, supernatant and
pellet fractions of leaf extract from CTB-ESAT6 tobacco (D), CTB-ESAT6 lettuce (E) and CTB-Mtb72F tobacco (F) transplastomic plants. (N,
Untransformed; H, homogenate; S, S1 & S2: supernatant; P, pellet; 1 to 4, transplastomic plants; C, purified bacterial CTB standard; C1, C2, C3 & C4:
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showed that there was a 22 fold increase in antigen content per
gram of lyophilized leaves, when compared to fresh leaves
(Figure 5B and 5C). There was no significant difference in
CTB-ESAT6 amount in lyophilized leaves stored for six months
CTB standards 25, 50, 75, 100 ng for densitometry). Immunoblot using rat anti-LipY antibody showing presence of expected band in LipY
transplastomic tobacco plants (G). Lane1, untransformed; Lanes 2 to 7, transformants. Immunoblot using rat anti-LipY antibody showing presence of
expected band in LipY transplastomic lettuce plants (H). Lane 1, Supernatant fraction of leaf extract from transplastomic plant; Lane 2, Homogenate
fraction of leaf extract from transplastomic plant; Lane 3, untransformed.
doi:10.1371/journal.pone.0054708.g003
Figure 4. Quantitation of vaccine antigens in transplastomic lines at different developmental stages and harvesting time. A,
Expression levels of tobacco CTB-ESAT6 (Nt) protein in percent total soluble protein (TSP) as a function of leaf age and harvesting time under normal
growth conditions determined by ELISA. B, Expression levels of tobacco CTB-Mtb72F (Nt) protein in percent TSP in young, mature and old leaves
collected from the transplastomic lines by ELISA. Expression levels of CTB-ESAT6 (Ls) protein in lettuce transplastomic lines in percent total protein
(TP) by densitometry at different leaf developmental stages (C) and at various time of harvest (D). 1 to 3, transplastomic lines. Expression levels of
CTB-ESAT6 (Nt) and CTB-Mtb72F (Nt) are reported as percentage of the total soluble protein whereas CTB-ESAT6 (Ls) is in percentage of the total
protein. Initially, ELISA was performed to quantify CTB-ESAT6 (Nt) in the total soluble protein but subsequent analysis of pellet, supernatant and
homogenate fractions of leaf extracts detected fusion protein in the insoluble fraction. Therefore, CTB-ESAT6 (Ls) fusion protein was estimated based
on percentage of total leaf protein. The CTB-Mtb72F fusion protein was quantitated based on percentage of the total soluble protein as the fusion
protein existed only in the soluble fraction. Data presented is mean 6 SD of triplicate experiments. Protein was extracted from three independent
plants and amount of CTB-fusion protein was quantified either by ELISA or by densitometry on western blots. Three independent measurements
were made to quantify expression levels of fusion protein and a mean 6 SD value was plotted on the graph.
doi:10.1371/journal.pone.0054708.g004
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when compared with latest lyophilized leaves suggesting that
lyophilized material was stable even after 6 months of storage at
room temperature (Figure 5D).
Binding of Chloroplast-derived CTB-ESAT6 to the GM1-
ganglioside Receptor
To evaluate whether CTB-ESAT6 fusion protein produced in
lettuce chloroplasts retained its biological function of binding to
the GM1 receptor, GM1- binding ELISA assay was performed. A
Figure 5. Lyophilization of CTB-ESAT6 lettuce leaves for long term storage and enrichment of antigenic fusion protein. A,
Preparation of capsules containing lyophilized powdered lettuce leaves expressing CTB-ESAT6 fusion protein for use as oral vaccine. B, Immunoblot
comparing amount of CTB-ESAT6 fusion protein in fresh and lyophilized lettuce leaves. Equal amount of lyophilized and fresh leaves was used for
protein extraction and equal volume of protein extract was loaded with dilutions of 1x, 10x and 20x; CTB, 50 ng CTB standard. C, CTB-ESAT6
expression levels in mg/g of fresh and lyophilized leaves. D, CTB-ESAT6 protein concentration (mg/g) in lyophilized leaves stored 0–6 months at room
temperature. Error bars represent standard deviation of mean.
doi:10.1371/journal.pone.0054708.g005
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pentameric structure of CTB protein is required for binding to its
receptor GM1- ganglioside in vivo [60,61]. CTB- ESAT6 plant
extract along with purified CTB protein showed strong binding
affinity to GM1 (Figure 6A & 6B). Untransformed plants and
bovine serum albumin (BSA) didn’t show binding to the GM1
receptor (Figure 6A & 6B). Effect of lyophilization on the binding
ability of CTB-ESAT6 fusion protein was also tested with GM1
ELISA binding assay. Extracts from CTB-ESAT6 lyophilized
lettuce leaves effectively bound to the GM1-ganglioside receptors
(Figure 6B). Further, serial dilution of extract from fresh,
lyophilized leaves and purified CTB showed decrease in absor-
bance accordingly (Figure 6B). GM1 binding of CTB-ESAT6
fusion protein from lyophilized and fresh lettuce leaves indicates
that the CTB in the fusion protein has its native pentameric
structure and has not been disrupted by its fusion to ESAT6 or by
the lyophilization process. Binding to GM1 receptor is essential for
antigen uptake in the gut.
Evaluation of Pore Formation in Red Blood Cell
Membranes Using Hemolysis Assay
Lettuce expressing CTB-ESAT6 protein is an oral edible
vaccine for TB; therefore there is no need to perform purification
of antigens. Hence, a tag such as histidine was not incorporated in
the coding sequence. To perform hemolysis assay, purification of
CTB-ESAT6 fusion protein is necessary. Therefore, CTB–ESAT6
fusion protein was purified from lettuce plants using immunoaffi-
nity purification with CTB antibody. Western blot analysis of
purified protein detected multiple bands corresponding to
monomeric 23 kDa, cleaved 15 kDa and aggregates or multimers
of .23 kDa molecular weight (Figure 7A). Based on densitometry
analysis, up to 40 mg/ml of 80% pure CTB–ESAT6 was obtained
and this concentration was further confirmed by ELISA. Silver
staining of purified protein showed two polypeptides of ,23 kDa
and ,15 kDa (Figure 7B). The trimeric 69 kDa fragment was not
observed in silver stained gels, probably due to lower concentra-
tion when compared with polypeptides of ,23 kDa and
,15 kDa. In addition, denaturing and reducing conditions should
disrupt the trimeric form of CTB-ESAT6 fusion protein into the
monomeric form. Presence of ,15 kDa protein band showed that
the cleavage occurred in the ESAT6 protein. The purified CTB-
ESAT6 protein was used for hemolysis assay.
Mycobacterium tuberculosis uses ESX-1 secretion system to export
virulence proteins during infection. ESAT-6 is one of the secreted
proteins in ESX-1 system and has been reported to play a role in
the escape of Mycobacterium from the phagolysosome [62] by
membrane pore formation [51]. Purified ESAT-6 has been shown
to cause dose dependent hemolysis in red blood cells by membrane
pore formation [51]. The red blood cell lysis by pore forming
proteins occurs by osmotic shock. The hemolytic effect of plant-
derived partially purified ESAT6 was investigated on red blood
cell membranes after two hour incubation. Hemolysis was
measured by the absorbance (O.D.) of the red blood cell
supernatant which contains hemoglobin. Partially purified CTB-
ESAT6 when solubilized resulted in dose dependent hemolysis.
CTB-ESAT6 formed aggregates in its native form and hence was
solubilized to dissociate the oligomeric protein. Purified protein
without solubilisation did not cause hemolysis at a concentration of
40 mg/ml (Figure 7C). After solubilisation, CTB-ESAT6 at
40 mg/ml protein concentration caused partial hemolysis of red
blood cells with an absorbance of 0.85. Decrease in absorbance to
0.4 was observed when the protein was diluted two fold
(Figure 7C). This indicated that the fusion did not modify
ESAT-6 protein’s ability to form pores and lysed red blood cell
membranes in a dose-dependent manner. Red blood cells
incubated with water resulted in complete lysis (absorbance of
1.9) as the cells swell and burst due to movement of water into cells
(hypotonic solution). Red blood cells incubated in PBS solution
were intact and therefore no absorbance was detected (Figure 7C).
Also, purified CTB protein suspended in PBS was analyzed to see
if there was any hemolytic effect shown by CTB (concentration of
40 mg/ml) but no effect was observed.
Figure 6. Functional evaluation of CTB-ESAT6 fusion protein in fresh and lyophilized lettuce leaves. A, Ganglioside GM1 ELISA binding
assay of CTB-ESAT6 derived from total leaf protein (TLP) of transplastomic plants. 1, 2:15 mg TLP from CTB-ESAT6 transplastomic plants; WT, 15 mg TLP
from untransformed lettuce plant; CTB, purified CTB standard; BSA, 50 ng bovine serum albumin. B, Ganglioside GM1 ELISA binding assay of CTB-
ESAT6 from fresh and lyophilized lettuce leaves. Fresh and lyophilized CTB-ESAT6 lettuce leaf extracts starting from 15 mg equal concentrations and
with decreasing two fold dilutions were analyzed for binding assay; Wild type, untransformed leaf extract; Purified CTB, 10 ng purified CTB standard.
doi:10.1371/journal.pone.0054708.g006
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Discussion
Recent advances in genetic engineering have increased the
potential of using plant chloroplasts for high level of foreign
protein expression, cost-effectiveness, scalability and safety of
recombinant biopharmaceuticals and vaccines [37,63,64]. To our
knowledge, this is the first report of expression of TB vaccine
antigens in chloroplasts. In this study, we expressed ESAT6,
Mtb72F and LipY, three ideal candidate antigens for TB vaccine
development in tobacco and lettuce chloroplasts. Results show an
efficient and stable expression of the recombinant fusion protein
CTB-ESAT6, CTB-Mtb72F and LipY protein in chloroplasts.
The main factors that are essential for practical development of
Figure 7. Hemolysis assay with antibody affinity purified CTB-ESAT6. A, Immunoblot with CTB antibody to confirm the presence of CTB-
ESAT6 fusion protein. S1, S2, S3:12.5, 25, 37.5 ng CTB standard; E1, E2, E3:5 ml of different elution fractions; B4IP, 10 mg of total protein extract from
CTB-ESAT6 transplastomic line before purification; WT, 10 mg of total protein extract from untransformed lettuce plant. B, Silver stained gel of affinity
purified CTB-ESAT6 fusion protein. Elution1, 1st elution; Elution2, 2nd elution; E1, E2, E3, 2E1:20 ml of different elution fractions of CTB-ESAT6; M,
0.4 ml protein standard marker. C, Hemolysis assay of ESAT6 with purified fusion protein CTB-ESAT6. Water causes complete hemolysis; E1 w/o sol,
40 mg/ml partially purified CTB-ESAT6 protein after 1st elution without solubilization; E1, 40 mg/ml partially purified CTB-ESAT6 protein after 1st
elution with solubilization; 2E1, 20 mg/ml partially purified CTB-ESAT6 protein after 2nd elution with solubilization; PBS, phosphate buffer saline
control; Elution/sol buffer, elution buffer used for protein elution/solubilisation; CTB, 40 mg/ml purified CTB. Standard deviations are represented by
error bars of mean. Values are of 2 independent experiments in duplicates.
doi:10.1371/journal.pone.0054708.g007
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oral plant vaccines are sufficient expression level of antigens in the
system to meet adequate dosage (leaf material) required for
immunization, stability and storage in addition to vaccine efficacy.
Chloroplast expression system is well suited for production of TB
vaccine antigens to achieve these goals.
In relation to antigen expression, CTB-ESAT6 tobacco plants
reached up to 7.5% of the TSP in the mature transgenic tobacco
leaves under normal illumination. The recombinant CTB-Mtb72F
accumulated up to 1.1% of TSP, which could be due to
heteroplasmy observed in transplastomic plants. The CTB-
Mtb72F plants were heteroplasmic even after additional rounds
of selection probably due to the instability caused by improper
folding of the fusion protein as GPGP hinge by itself was not
capable of preventing steric hindrance, as reported previously for
CTB-FIX [56]. In the greenhouse, CTB-Mtb72F heteroplasmic
plants were grown without antibiotic selection. Leaves harvested
from the greenhouse grown plants showed expression and
accumulation of CTB-Mtb72F (Figure 3F and 4B) confirming
transgene expression in the absence of any selection. Persistence of
such heteroplasmy in subsequent generations of transplastomic
lines has been observed previously [65]. CTB-Mtb72F and LipY
were expressed in LAMD, a low nicotine variety of tobacco that
may be a suitable system for oral delivery of vaccine antigens. The
CTB–ESAT6 lettuce transplastomic plants have modest expres-
sion levels of 0.75% of total leaf protein (TP). In comparison to the
tobacco system, earlier studies have shown lettuce to have lower
expression levels with some antigens. In case of CTB–AMA1
fusion protein, a higher level of expression of ,13% TSP was
found in tobacco when compared to ,7% TSP in lettuce [32].
The variation in expression levels of recombinant proteins can be
due to many factors including nature of protein, plant system used,
environmental conditions, protein stability in chloroplasts and
regulatory elements present in expression cassettes [64]. Since
tobacco system expressed higher levels of CTB-ESAT6, this
variation could be due to protein instability in lettuce chloroplasts.
Our results indicated that approximately 950 mg of CTB-
ESAT6 protein can be obtained per gram fresh weight of mature
tobacco leaves under normal illumination. Accordingly, 80mg of
CTB-ESAT6 can be obtained from a single tobacco plant and
a total of 1.92 kg can be produced from an acre of land based on
three cuttings in a year. For some commercial tobacco cultivars
whose yield are almost 20 fold more than that of experimental
cultivar Petite Havana [66], it is expected to produce more vaccine
antigens at lower cost of vaccination for larger populations. The
CTB-ESAT6 lettuce plants expressed 11.2 mg/g of antigen (fresh
weight mature leaf) whereas lyophilization increased the yield 22
fold as the antigenic content built up to 249 mg/g of lyophilized
leaves. There is no need to produce 22 times more fresh leaf for
each dose but lyophilization reduces the biomass requirement for
packaging by 22-fold. Therefore, adequate amounts of transgenic
protein are available for oral delivery. In human trials for TB
subunit vaccine ESAT-6, 50 mg of vaccine antigen was injected
intramuscularly [21]. So if we hypothesize that 50 mg were to be
orally delivered, based on quantification of antigenic content, only
200 mg of lyophilized material would be needed. Lyophilized
lettuce expressing antigens has been successfully used in orally
delivered plant vaccine animal studies [67,68]. Accordingly, only
9 mg of lyophilized tissue expressing hepatitis B surface in the
form of tablets was orally fed to mice with an interval of 60 days
between priming and boosting to induce an immune response.
Tablets or capsules could provide the means to antigen
standardization and dosage control and are easy for distribution.
Expression level of any vaccine antigen, including Mtb72F will
vary depending upon the developmental stage, duration of
illumination, time of harvest, etc. Therefore, each batch of leaves
must be quantified after harvest and lyophilization and then
packaged into capsules so that desired dosage is maintained and
delivered. Long term stability of antigens after storage at room
temperature should facilitate in maintaining proper dosage of
antigens in capsules. Therefore, dosage is not determined by
expression level in leaves but it should be controlled in capsules in
each batch of production.
Lettuce (Lactuca sativa) was chosen as an alternative to tobacco
for expression of TB vaccine antigens because it is a leafy vegetable
and has great commercial value. The lettuce CTB-ESAT6 plants
showed modest expression levels, which can be overcome with
lyophilization, a process of freeze drying. Since lettuce has high
water content (95%), it can be freeze dried to a greater magnitude
than other plant leaves. Lettuce is a relatively easy plant to grow
with no special conditions except cooler environment. Since it is
a leafy vegetable, more antigen could be concentrated by
lyophilization of leaf tissue. Furthermore, lyophilization process
has been shown to remove microbes as opposed to the fresh lettuce
leaves which harbored ,6000 cfu/g microbes [57,69]. The CTB-
ESAT6 protein was stable in lyophilized material stored at room
temperature for six months. (Figure 5D). This stability of antigens
in plant tissue could help in eliminating cold chain during storage
and distribution required for conventional vaccines. Also, harvest-
ing leaves before appearance of flowers maximizes transgene
containment.
The ability of CTB-ESAT6 to form pentamers facilitates
binding to GM1 ganglioside receptors and increased antigen
uptake. Activity of ESAT-6 has been characterized as a cytolysin
that can disrupt lipid bilayers [70] and pore formation in cell
membranes [51]. Hemolysis assay established the ability of
partially purified CTB-ESAT6 to create partial lysis of red blood
cells. Plant derived CTB-ESAT6 has been shown to retain its
biological activity and has potential to be an effective oral vaccine.
Production of an oral subunit vaccine against tuberculosis in
chloroplast is a promising strategy to overcome the cost constraints
such as production, purification, processing, cold storage,
transportation and delivery linked to large vaccination campaigns,
especially with the increasing TB incidence in some developing
countries where there is a dire need of such vaccines. The
estimated costs associated with production and delivery of the
recombinant proteins in bacterial, insects or mammalian cells is
much higher when compared to plants [71]. Easy and unlimited
scalability of protein production and absence of the viral
contamination can make plant-derived biologicals, economical
and safer for large-scale production [37,72,73]. Production cost of
antigen in GMP facility greenhouse has been estimated to be 100–
220 fold less than other current production systems [74]. However,
oral delivery of antigens bioencapsulated in plant cells eliminates
the highly expensive purification, cold storage, transportation and
sterile injections, significantly reducing their cost.
BCG, the only current TB vaccine is delivered parenterally and
shows variable protection. There is a need for alternative routes of
vaccine delivery targeting the mucosa which is the site of invasion
of Mycobacterium tuberculosis. Oral vaccines confer both mucosal
(IgA) and systemic immune response [75]. In order to combat the
TB disease with a safer vaccine, subunit vaccines are being
pursued with recombinant TB antigens. Many TB vaccine
candidates are in clinical trials such as recombinant BCG
candidates VPM1002, rBCG30 and there are booster vaccine
candidates such as MVA85A, Crucell Ad35, which employ non
virulent viral vectors for delivery [76]. A key latent phase antigen,
a-crystallin, has been analyzed in guinea pigs to boost the BCG
induced immunity by BCG prime-DNA boost treatment and
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conferred strong protection when compared with BCG vaccina-
tion [11]. Currently, an ideal strategy to combat TB is to
administer BCG to infants and later on boost immunity by
effective subunit booster vaccine. The production of CTB-ESAT6,
CTB-Mtb72F and LipY in plant chloroplasts provides suitable
plant based oral booster vaccines. Following priming with BCG,
oral boosters of plant based TB vaccine antigens has potential to
effectively provoke mucosal as well as systemic immunity.
Chloroplast-derived vaccine candidates including CTB-AMA1,
CTB-MSP1 and F1-V fusion protein has been effectively
employed in a subcutaneous prime and oral boost treatment
regimen [29,32]. In addition, after challenge with fatal dosage of
aerosolized Y. pestis, orally immunized mice showed enhanced
immunity and protection when compared with subcutaneous
injections [29]. Moreover, vaccine antigens produced in plants are
bioencapsulated and protects the antigen from hostile acidic
environment of stomach upon oral delivery. After reaching the
gut, microbes colonizing gut digest plant cell walls and vaccine
antigens are presented to the immune system of the gut.
For evaluation of the TB vaccine antigens expressed in
chloroplasts, studies will be performed in future to test their
immunogenicity in suitable animal models. Lettuce, an edible crop
plant and LAMD, low nicotine tobacco variety are ideal systems
for oral delivery of CTB-ESAT6, LipY and CTB-Mtb72F and can
pave the way for future cost-effective oral TB booster vaccines.
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